The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111 … M Bond, G Rogers, J Peters, R Anderson, M Hoyle, A Miners, T Moxham, ... NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2012 | 376 | 2012 |
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis M Stevenson, ML Jones, E De Nigris, N Brewer, S Davis, J Oakley NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2005 | 350 | 2005 |
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis JA Kanis, M Stevenson, EV McCloskey, S Davis, M Lloyd-Jones NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2007 | 210 | 2007 |
Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation S Ward, E Simpson, S Davis, D Hind, A Rees, A Wilkinson NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2007 | 134 | 2007 |
Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model C Hyde, J Peters, M Bond, G Rogers, M Hoyle, R Anderson, M Jeffreys, ... Age and ageing 42 (1), 14-20, 2013 | 129 | 2013 |
The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women M Stevenson, S Davis, M Lloyd-Jones, C Beverley NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2007 | 93 | 2007 |
Implantable loop recorders are cost-effective when used to investigate transient loss of consciousness which is either suspected to be arrhythmic or remains unexplained S Davis, M Westby, D Pitcher, S Petkar Europace 14 (3), 402-409, 2012 | 47 | 2012 |
The hospitalisation costs and out-patient costs of fragility fractures MD Stevenson, SE Davis, JA Kanis Women's Health Medicine 3 (4), 149-151, 2006 | 47 | 2006 |
The cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in patients with end-stage renal disease A Brennan, R Akehurst, S Davis, H Sakai, V Abbott Value in health 10 (1), 32-41, 2007 | 42 | 2007 |
Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration N Bansback, S Davis, J Brazier Eye 21 (12), 1455-1463, 2006 | 36 | 2006 |
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration J Karnon, C Czoski-Murray, K Smith, C Brand, U Chakravarthy, S Davis, ... HEALTH TECHNOLOGY ASSESSMENT-SOUTHAMPTON- 12 (27), 2008 | 35 | 2008 |
A review of the psychometric performance of the EQ-5D in people with urinary incontinence S Davis, A Wailoo Health and Quality of Life Outcomes 11 (1), 20, 2013 | 34 | 2013 |
The cost-effectiveness of multi-component interventions to prevent delirium in older people undergoing surgical repair of hip fracture A Akunne, S Davis, M Westby, J Young European Journal of Orthopaedic Surgery & Traumatology 24 (2), 187-195, 2014 | 28 | 2014 |
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisal J Tosh, R Archer, S Davis, M Stevenson, JW Stevens Pharmacoeconomics 31 (8), 653-661, 2013 | 22 | 2013 |
Analyses of the cost-effectiveness of pooled alendronate and risedronate, compared with strontium ranelate, raloxifene, etidronate and teriparatide M Stevenson, S Davis DSU Report, 2006 | 19 | 2006 |
Transient loss of consciousness (‘blackouts’) management in adults and young people M Westby, S Davis, I Bullock, P Miller, P Cooper, N Turnbull London: National Clinical Guideline Centre for Acute and Chronic Conditions …, 2010 | 16 | 2010 |
Tilt testing is more cost-effective than implantable loop recorder monitoring as a means of directing pacing therapy in people with recurrent episodes of suspected vasovagal … S Davis, M Westby, S Petkar, D Pitcher Heart 99 (11), 805-810, 2013 | 14 | 2013 |
Transient loss of consciousness--initial assessment, diagnosis, and specialist referral: summary of NICE guidance. M Westby, I Bullock, PN Cooper, S Davis, Guideline Development Group BMJ (Clinical research ed.) 341, c4457, 2010 | 10 | 2010 |
How do we evaluate technologies that are not cost effective at zero price S Davis, R Akehurst Value and Outcomes Spotlight 359, 6-8, 2016 | 9 | 2016 |
Transient loss of consciousness: summary of NICE guidance S Petkar, I Bullock, S Davis, P Cooper Heart 99 (13), 901-903, 2013 | 5 | 2013 |